Prosight Management »

Transmedics Group shares owned by Prosight Management

Quarter-by-quarter ownership of Transmedics Group (TMDX) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Transmedics Group

Tip: Access up to 7 years of quarterly data

All positions including Transmedics Group held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transmedics Group by Prosight Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $497k 5.0k 99.41

More positions owned by Prosight Management

Nektar Therapeutics Com New (NKTR)
Boston Scientific Corporation (BSX)
Janux Therapeutics (JANX)
Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr
Genedx Holdings Corp Com Cl A (WGS)
Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Alnylam Pharmaceuticals (ALNY)
Meiragtx Holdings (MGTX)
Alkermes SHS (ALKS)
Syndax Pharmaceuticals (SNDX)
Veeva Sys Cl A Com (VEEV)
Zymeworks Del (ZYME)

View all positions for Prosight Management

Top funds holding Transmedics Group

BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Invesco
Ubs Global Asset Management Americas
Nomura Asset Management International
Susquehanna International
Goldman Sachs Group
Geode Capital Management
Hood River Capital Management
Morgan Stanley
UBS Group
Eventide Asset Management

View all funds holding Transmedics Group